Operating income increased 29.6%
Operating income changed +29.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +29.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Total assets changed -18.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed -29.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed +212557 basis points from the comparable as-filed period.
Revenue changed +240.6% from the comparable as-filed period.
Research & development changed -55.0% from the comparable as-filed period.
Operating cash flow changed +16.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Shares outstanding changed +0.4% from the comparable as-filed period. The change ranks at the 100th percentile of 7 prior comparable changes.
Trade receivables changed -100.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.